This map shows the geographic impact of Mervyn Israel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mervyn Israel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mervyn Israel more than expected).
This network shows the impact of papers produced by Mervyn Israel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mervyn Israel. The network helps show where Mervyn Israel may publish in the future.
Co-authorship network of co-authors of Mervyn Israel
This figure shows the co-authorship network connecting the top 25 collaborators of Mervyn Israel.
A scholar is included among the top collaborators of Mervyn Israel based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mervyn Israel. Mervyn Israel is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Ahmed, N., et al.. (2012). Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles. SHILAP Revista de lepidopterología.9 indexed citations
2.
Hofmann, Polly A., Trevor W. Sweatman, Ganesh R. Panta, et al.. (2004). Cardioprotective effects of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate (AD 198). Cancer Research. 64. 258–259.2 indexed citations
3.
Israel, Mervyn, et al.. (1998). Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities.. PubMed. 10(4). 209–17.6 indexed citations
Potmĕsil, M, S Kirschenbaum, Mervyn Israel, et al.. (1983). Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells.. PubMed. 43(8). 3528–33.41 indexed citations
11.
Krishan, Awtar, Kamla Dutt, Mervyn Israel, & Ram Ganapathi. (1981). Comparative effects of adriamycin and N-trifluoroacetyladriamycin-14-valerate on cell kinetics, chromosomal damage, and macromolecular synthesis in vitro.. PubMed. 41(7). 2745–50.30 indexed citations
12.
Krishan, Awtar & Mervyn Israel. (1979). Excitation and quantitation of adriamycin and related anthracyclines by laser flow cytometry.1 indexed citations
13.
Garnick, Marc B., William D. Ensminger, & Mervyn Israel. (1979). A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.. PubMed. 39(10). 4105–10.64 indexed citations
14.
Krishan, Awtar, Ram Ganapathi, & Mervyn Israel. (1978). Effect of adriamycin and analogs on the nuclear fluorescence of propidium iodide-stained cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3656–62.39 indexed citations
15.
Israel, Mervyn, P M Wilkinson, William J. Pegg, & Emil Frei. (1978). Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2). 365–70.41 indexed citations
16.
Israel, Mervyn, et al.. (1977). Hepatobiliary metabolism and excretion of adriamycin (ADR) in man [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(5). 639P–639P.3 indexed citations
17.
Krishan, Awtar, Mervyn Israel, Edward J. Modest, & Emil Frei. (1976). Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate.. PubMed. 36(6). 2108–9.53 indexed citations
18.
Israel, Mervyn, Edward J. Modest, & Emil Frei. (1975). N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.. PubMed. 35(5). 1365–8.113 indexed citations
Israel, Mervyn, et al.. (1965). Pyrimidine Derivatives VII. Journal of Pharmaceutical Sciences. 54(11). 1626–1632.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.